Tazemetostat, as an EZH2 methyltransferase inhibitor, commonly has side effects involving hematological toxicity, gastrointestinal reactions, a...
Pazopanib is a multi-target tyrosine kinase inhibitor primarily used for the treatment of advanced renal cell carcinoma and soft tissue sarcoma...
Pazopanib, as a multi-target tyrosine kinase inhibitor, commonly has side effects including liver toxicity, hypertension, and hematological abn...
Tofacitinib, as a JAK inhibitor, requires special attention to the risk of infection, cardiovascular events, and serious adverse reactions such...
Tofacitinib is a JAK inhibitor primarily used to treat autoimmune diseases such as rheumatoid arthritis. Its contraindications include severe i...
Erdafitinib, as an FGFR inhibitor, commonly has side effects such as hyperphosphatemia, ocular lesions, and gastrointestinal reactions, which n...
Erdafitinib is an FGFR kinase inhibitor used to treat specific types of advanced urothelial carcinoma. Attention should be paid to adverse reac...
The side effects of Semaglutide tablets mainly involve gastrointestinal reactions and metabolic abnormalities, and most symptoms can be relieve...
Semaglutide is a GLP-1 receptor agonist, which is mainly used for blood glucose control in patients with type 2 diabetes. Its applicable popula...
Rivastigmine transdermal patch is used to treat Alzheimer's disease and Parkinson's disease dementia, and its transdermal administration can re...